USA Percutaneous Coronary Interventional Landscape, Procedure Volumes, Brand Perception and Future Outlook (2019-2022)

The USA Percutaneous Coronary Interventional landscape, Procedure Volumes, Brand Perception and Future Outlook report is the first ever syndicated report that covers the standard of care, procedure volumes and physician perception of the medical devices used in PCI interventions. The report is based on responses from performing physicians in Interventional Cardiology departments from Academic/university, community teaching and non-teaching hospitals in USA.
The number of Percutaneous Coronary interventional procedures were estimated to be around 676,450 and diagnostic /imaging and monitoring procedures are estimated to be around 1,130,642 in 2019. The 5-year forecast of procedure volumes till 2022 along with the headwinds and tailwinds are covered comprehensively in the report. The report has details on percutaneous interventional procedures including balloon angioplasty, balloon angioplasty with stenting, direct stenting, chronic total occlusion (CTO) and atherectomy. The report captures interventional devices such as stents, angioplasty balloons, embolic protection device, guidewires, and catheters. The procedure volumes are presented by primary route of access used for the intervention and by type of technique.
The report also highlights the PCI care continuum and offers valuable insights on patient referrals pathway, hospital structure and utilization, physician treatment selection criteria, current and upcoming policies for diagnosis and treatment, and payer coverage.
The report provides physician’s brand perception and ranks medical device companies based on 15 KPI’s such as technology, clinical evidence, patient outcome, etc. Moreover, diligent examination of physician’s brand usage and brand satisfaction levels and the factors such as ease of use of device, availability of clinical data among others effecting brand usage have been covered.
The report provides information on the future trends such as decrease in the overall procedural cost may result in increased adoption of atherectomy, introduction of new angioplasty technique will drive higher volume are some of the potential game changers to watch out for in the growing PCI interventional devices market.
This report will help percutaneous coronary interventional devices companies understand the percutaneous coronary intervention landscape in USA, the current and future procedure volumes, the brand perception, device usage trends, and challenges faced by interventionalists in USA. The report is a great resource to plan your market strategy to capitalize on upcoming trends and potential disruptors in the PCI interventional devices market.
The deliverable includes a 100+ slide MS PowerPoint report and an MS Excel-based 5-Year market forecast model.
Contact us for further details regarding the exclusive data and insights in the report or for an exploratory analyst walk through of the report.

About Us: Cetas Healthcare is a global market research agency with an exclusive focus in the medical device industry. We have offices in Singapore, Netherlands, USA, and India. We have an extensive practice in the Cardiovascular space and have prior experience on several therapy areas. We offer custom research solutions and syndicated reports to our clients. We work regularly with some of the top global medical device companies such as GE Healthcare, Boston Scientific, Medtronic, Baxter, B Braun, BD, etc. and help them in product development and product management.

    Drop Us A Line

    Lorem ipsum dolor amet consectetur adipisicing eliteiuim sete eiusmod tempor incididunt ut
    labore etnalom dolore magna aliqua udiminimate veniam quis norud.

    We provide the best insights for your business